Identification
- Summary
Paspalum notatum pollen is an extract from Paspalum notatum pollen used in allergy testing.
- Generic Name
- Paspalum notatum pollen
- DrugBank Accession Number
- DB10349
- Background
Paspalum notatum pollen is the pollen of the Paspalum notatum plant. Paspalum notatum pollen is mainly used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Bahia grass pollen extract
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAcebutolol The risk of a hypersensitivity reaction to Paspalum notatum pollen is increased when it is combined with Acebutolol. Atenolol The risk of a hypersensitivity reaction to Paspalum notatum pollen is increased when it is combined with Atenolol. Betaxolol The risk of a hypersensitivity reaction to Paspalum notatum pollen is increased when it is combined with Betaxolol. Bisoprolol The risk of a hypersensitivity reaction to Paspalum notatum pollen is increased when it is combined with Bisoprolol. Carvedilol The risk of a hypersensitivity reaction to Paspalum notatum pollen is increased when it is combined with Carvedilol. - Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Bahia Grass Solution 20000 [PNU]/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US 
Bahia Grass Solution 0.001 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Bahia Grass Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Nelco Laboratories, Inc. 1972-08-29 Not applicable US Bahia Grass Solution 0.05 g/1mL Intradermal; Percutaneous; Subcutaneous Greer Laboratories, Inc. 1981-09-15 Not applicable US Bahia Grass Injection, solution 0.05 g/1mL Intradermal; Subcutaneous Antigen Laboratories, Inc. 1974-03-23 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Mixture of Standardized and Non-Standardized Southeastern Grasses Paspalum notatum pollen (0.0167 g/1mL) + Cynodon dactylon pollen (3333 [BAU]/1mL) + Phleum pratense pollen (33333 [BAU]/1mL) Injection, solution Intradermal; Subcutaneous Antigen Laboratories, Inc. 1997-06-13 Not applicable US Treatment Set TS336682 Paspalum notatum pollen (0.0004 g/1mL) + Canis lupus familiaris hair (0.005 g/1mL) + Cynodon dactylon pollen (80 [BAU]/1mL) + Dactylis glomerata pollen (4000 [BAU]/1mL) + Dermatophagoides farinae (1000 [AU]/1mL) + Dermatophagoides pteronyssinus (1000 [AU]/1mL) + Felis catus hair (400 [BAU]/1mL) + Lolium perenne pollen (160 [BAU]/1mL) + Phleum pratense pollen (800 [BAU]/1mL) + Poa pratensis pollen (800 [BAU]/1mL) + Rhizopus stolonifer (0.005 g/1mL) + Sorghum halepense pollen (0.0004 g/1mL) Injection, solution Intradermal; Subcutaneous Antigen Laboratories, Inc. 1986-10-31 Not applicable US Treatment Set TS339754 Paspalum notatum pollen (0.002 g/1mL) + Ambrosia artemisiifolia pollen (800 [AU]/1mL) + Betula populifolia pollen (0.002 g/1mL) + Carya illinoinensis pollen (0.002 g/1mL) + Carya tomentosa pollen (0.002 g/1mL) + Cynodon dactylon pollen (400 [BAU]/1mL) + Felis catus hair (16 [BAU]/1mL) + Festuca pratensis pollen (4000 [BAU]/1mL) + Plantago lanceolata pollen (0.002 g/1mL) + Poa pratensis pollen (4000 [BAU]/1mL) + Populus deltoides pollen (0.002 g/1mL) + Sorghum halepense pollen (0.002 g/1mL) Injection, solution Intradermal; Subcutaneous Antigen Laboratories, Inc. 1986-10-31 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- V003SHB7VK
- CAS number
- Not Available
References
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Intradermal; Subcutaneous 0.1 g/1mL Injection, solution Intradermal; Subcutaneous 10000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 20000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous 40000 [PNU]/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.001 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 0.05 g/1mL Solution Intradermal; Percutaneous; Subcutaneous 1000 [PNU]/1mL Solution Intradermal; Percutaneous; Subcutaneous 20000 [PNU]/1mL Solution Intradermal; Percutaneous; Subcutaneous 40000 [PNU]/1mL Injection Cutaneous; Intradermal; Subcutaneous 0.05 g/1mL Injection, solution Percutaneous; Subcutaneous 1 g/20mL Injection, suspension Subcutaneous 10000 [PNU]/1mL Injection, suspension Subcutaneous 20000 [PNU]/1mL Injection, solution Intradermal; Subcutaneous Injection, solution Intradermal 1000 [PNU]/1mL Injection, solution Percutaneous 0.05 g/1mL Injection, solution Subcutaneous 0.001 g/1mL Injection, solution Subcutaneous 0.05 g/1mL Injection, solution Subcutaneous 0.10 g/1mL Injection, solution Subcutaneous 10000 [PNU]/1mL Injection, solution Subcutaneous 20000 [PNU]/1mL Injection, solution Subcutaneous 40000 [PNU]/1mL Injection, solution Intradermal 500 [PNU]/1mL Injection, solution Percutaneous; Subcutaneous 0.05 g/1mL Injection, solution Percutaneous; Subcutaneous 0.1 g/1mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:03 / Updated at June 12, 2020 16:53